The coronavirus vaccine is on track to be the fastest ever developed
Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall. THE NEW YORKER
Pending the results of a Phase III efficacy trial this summer, a vaccine produced by the biotech company Moderna could be ready for approval as soon as the fall. THE NEW YORKER